Found: 48
Select item for more details and to access through your institution.
Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase‐III trials and the real‐life clinical practice presented at the European Academy of Dermatology and Venereology Congress 2022.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, p. 3, doi. 10.1111/jdv.19636
- By:
- Publication type:
- Article
The Disease Burden of Generalized Pustular Psoriasis: Real-World Evidence From CorEvitas’ Psoriasis Registry.
- Published in:
- Journal of Psoriasis & Psoriatic Arthritis, 2022, v. 7, n. 2, p. 71, doi. 10.1177/24755303221079814
- By:
- Publication type:
- Article
Long‐term safety of risankizumab from 17 clinical trials in patients with moderate‐to‐severe plaque psoriasis*.
- Published in:
- British Journal of Dermatology, 2022, v. 186, n. 3, p. 466, doi. 10.1111/bjd.20818
- By:
- Publication type:
- Article
Three‐year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 12, p. 2398, doi. 10.1111/jdv.17486
- By:
- Publication type:
- Article
Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 12, p. 2409, doi. 10.1111/jdv.17520
- By:
- Publication type:
- Article
The risk of malignancy in patients with secukinumab‐treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow‐up.
- Published in:
- British Journal of Dermatology, 2021, v. 185, n. 5, p. 935, doi. 10.1111/bjd.20136
- By:
- Publication type:
- Article
Efficacy and safety of apremilast in patients with moderate‐to‐severe plaque psoriasis of the scalp: results up to 32 weeks from a randomized, phase III study.
- Published in:
- British Journal of Dermatology, 2021, v. 185, n. 4, p. 840, doi. 10.1111/bjd.20083
- By:
- Publication type:
- Article
Long‐term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo‐controlled studies.
- Published in:
- British Journal of Dermatology, 2021, v. 184, n. 4, p. 640, doi. 10.1111/bjd.19314
- By:
- Publication type:
- Article
Editorial: fixed‐dose combination calcipotriol/betamethasone dipropionate foam in the treatment of patients with psoriasis.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, p. 3, doi. 10.1111/jdv.17026
- By:
- Publication type:
- Article
Addressing challenges associated with long‐term topical treatment and benefits of proactive management in patients with psoriasis.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, p. 35, doi. 10.1111/jdv.17053
- By:
- Publication type:
- Article
Secukinumab maintains superiority over ustekinumab in clearing skin and improving quality of life in patients with moderate to severe plaque psoriasis: 52‐week results from a double‐blind phase 3b trial (CLARITY).
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 1, p. 135, doi. 10.1111/jdv.16558
- By:
- Publication type:
- Article
Safety in moderate‐to‐severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti‐tuberculosis treatments concomitantly: results from pooled phase 3 VOYAGE 1 & VOYAGE 2 trials.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2020, v. 34, n. 8, p. 1744, doi. 10.1111/jdv.16460
- By:
- Publication type:
- Article
Dupilumab as a treatment for generalized idiopathic pruritus: a report of two cases.
- Published in:
- British Journal of Dermatology, 2020, v. 182, n. 6, p. 1494, doi. 10.1111/bjd.18852
- By:
- Publication type:
- Article
Continued treatment with secukinumab is associated with high retention or regain of response.
- Published in:
- British Journal of Dermatology, 2020, v. 182, n. 1, p. 67, doi. 10.1111/bjd.17991
- By:
- Publication type:
- Article
The efficacy of secukinumab with continued use in the treatment of psoriasis.
- Published in:
- British Journal of Dermatology, 2020, v. 182, n. 1, p. e22, doi. 10.1111/bjd.18653
- By:
- Publication type:
- Article
苏金单抗持续用于治疗银屑病的疗效.
- Published in:
- British Journal of Dermatology, 2020, v. 182, n. 1, p. e39, doi. 10.1111/bjd.18670
- By:
- Publication type:
- Article
Use of dose–exposure–response relationships in Phase 2 and Phase 3 guselkumab studies to optimize dose selection in psoriasis.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2019, v. 33, n. 11, p. 2082, doi. 10.1111/jdv.15668
- By:
- Publication type:
- Article
A new era in the treatment of atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2019, v. 181, n. 4, p. 658, doi. 10.1111/bjd.18349
- By:
- Publication type:
- Article
Itch: an under‐recognized problem in psoriasis.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2019, v. 33, n. 8, p. 1465, doi. 10.1111/jdv.15450
- By:
- Publication type:
- Article
Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross‐sectional analysis from the US‐based Corrona Psoriasis Registry.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2019, v. 33, n. 5, p. 886, doi. 10.1111/jdv.15443
- By:
- Publication type:
- Article
Itch relief in patients with psoriasis: effectiveness of calcipotriol plus betamethasone dipropionate foam.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2019, v. 33, n. 4, p. 709, doi. 10.1111/jdv.15393
- By:
- Publication type:
- Article
Certolizumab pegol for the treatment of patients with moderate‐to‐severe chronic plaque psoriasis: pooled analysis of week 16 data from three randomized controlled trials.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2019, v. 33, n. 3, p. 546, doi. 10.1111/jdv.15258
- By:
- Publication type:
- Article
Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate‐to‐severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE‐2 and AMAGINE‐3.
- Published in:
- British Journal of Dermatology, 2018, v. 179, n. 2, p. 320, doi. 10.1111/bjd.16464
- By:
- Publication type:
- Article
Impact of ixekizumab treatment on skin-related personal relationship difficulties in moderate-to-severe psoriasis patients: 12-week results from two Phase 3 trials.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2017, v. 31, n. 11, p. 1867, doi. 10.1111/jdv.14377
- By:
- Publication type:
- Article
Reaching complete or near-complete resolution of psoriasis: benefit and risk considerations.
- Published in:
- British Journal of Dermatology, 2017, v. 177, n. 2, p. 587, doi. 10.1111/bjd.15463
- By:
- Publication type:
- Article
Ustekinumab as therapy for psoriasis in a 2-year-old girl.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2016, v. 30, n. 11, p. e109, doi. 10.1111/jdv.13348
- By:
- Publication type:
- Article
Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up.
- Published in:
- British Journal of Dermatology, 2015, v. 172, n. 5, p. 1371, doi. 10.1111/bjd.13469
- By:
- Publication type:
- Article
Physician perceptions and experience of current treatment in actinic keratosis.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2015, v. 29, n. 2, p. 298, doi. 10.1111/jdv.12530
- By:
- Publication type:
- Article
Do we need a patient satisfaction score?
- Published in:
- British Journal of Dermatology, 2014, v. 170, n. 3, p. 494, doi. 10.1111/bjd.12867
- By:
- Publication type:
- Article
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up.
- Published in:
- British Journal of Dermatology, 2013, v. 168, n. 4, p. 844, doi. 10.1111/bjd.12214
- By:
- Publication type:
- Article
Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the international psoriasis council.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2011, v. 25, n. 10, p. 1130, doi. 10.1111/j.1468-3083.2011.04113.x
- By:
- Publication type:
- Article
Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2011, v. 25, n. 7, p. 758, doi. 10.1111/j.1468-3083.2010.03932.x
- By:
- Publication type:
- Article
Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies.
- Published in:
- British Journal of Dermatology, 2011, v. 164, n. 4, p. 862, doi. 10.1111/j.1365-2133.2011.10257.x
- By:
- Publication type:
- Article
Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference.
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Tumour necrosis factor-α blockers in the treatment of psoriasis.
- Published in:
- British Journal of Dermatology, 2010, v. 162, n. 6, p. 1169, doi. 10.1111/j.1365-2133.2010.09835.x
- By:
- Publication type:
- Article
Topical corticosteroids in psoriasis: strategies for improving safety.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2010, v. 24, n. 2, p. 119, doi. 10.1111/j.1468-3083.2009.03358.x
- By:
- Publication type:
- Article
Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial.
- Published in:
- British Journal of Dermatology, 2010, v. 162, n. 1, p. 137, doi. 10.1111/j.1365-2133.2009.09491.x
- By:
- Publication type:
- Article
Expanding the therapeutic options for psoriatic conditions.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Alefacept in the Treatment of Psoriasis in Patients for Whom Conventional Therapies Are Inadequate.
- Published in:
- Dermatology (10188665), 2005, v. 211, n. 3, p. 256, doi. 10.1159/000087020
- By:
- Publication type:
- Article
Etanercept: A Review of its Use in the Management of Plaque Psoriasis and Psoriatic Arthritis.
- Published in:
- American Journal of Clinical Dermatology, 2005, v. 6, n. 2, p. 121, doi. 10.2165/00128071-200506020-00010
- By:
- Publication type:
- Article
Expanding the therapeutic options for psoriatic conditions.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
Actinic keratosis: epidemiology and progression to squamous cell carcinoma.
- Published in:
- British Journal of Dermatology, 2003, v. 149, p. 31, doi. 10.1046/j.0366-077X.2003.05621.x
- By:
- Publication type:
- Article
The cost of psoriasis treatment.
- Published in:
- 2001
- By:
- Publication type:
- Editorial
Combination therapy with vitamin D analogues.
- Published in:
- British Journal of Dermatology, 2001, v. 144, p. 27, doi. 10.1046/j.1365-2133.2001.00039.x
- By:
- Publication type:
- Article
Clobetasol Propionate Foam, 0.05%: A Viewpoint by Mark Lebwohl and Amy Krupnick.
- Published in:
- American Journal of Clinical Dermatology, 2001, v. 2, n. 2, p. 93, doi. 10.2165/00128071-200102020-00006
- By:
- Publication type:
- Article
Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice.
- Published in:
- Carcinogenesis, 1998, v. 19, n. 8, p. 1509, doi. 10.1093/carcin/19.8.1509
- By:
- Publication type:
- Article
Tamoxifen reduces endogenous and UV light-induced oxidative damage to DNA, lipid and protein in vitro and in vivo.
- Published in:
- Carcinogenesis, 1998, v. 19, n. 6, p. 1013, doi. 10.1093/carcin/19.6.1013
- By:
- Publication type:
- Article
Inhibition of ultraviolet B (UVB)-induced c-fos and c-jun expression in vivo by a tyrosine kinase inhibitor genistein.
- Published in:
- Carcinogenesis, 1998, v. 19, n. 4, p. 649, doi. 10.1093/carcin/19.4.649
- By:
- Publication type:
- Article